On September 30^th, Canada, the U.S. and Mexico reached an agreement in regards to the renegotiation of the North American Free Trade Agreement (NAFTA).  The new United States-Mexico-Canada Agreement (USMCA) will have the following influence on Intellectual Property:

• • The term of protection for new innovative drug products containing a medicinal ingredient not yet approved in Canada will increase to 10 years (from 8 years).
  • The USMCA will allow for the term of a patent to be adjusted based on unnecessary or unreasonable delay in the processing of a patent application.
  • Copyright protection will increase to be the life of the author plus 70 years (from life of the author plus 50 years).

For more information, please see the following: Chapter 20: Intellectual Property Rights